Detalles de la búsqueda
1.
Implementation of an intravenous sotalol initiation protocol: Implications for feasibility, safety, and length of stay.
J Cardiovasc Electrophysiol;
34(3): 502-506, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36640424
2.
Randomized Controlled Trial of Automated Directly Observed Therapy for Measurement and Support of PrEP Adherence Among Young Men Who have Sex with Men.
AIDS Behav;
27(2): 719-732, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35984607
3.
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
AIDS Behav;
26(12): 4107-4114, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687192
4.
DOT Diary: Developing a Novel Mobile App Using Artificial Intelligence and an Electronic Sexual Diary to Measure and Support PrEP Adherence Among Young Men Who Have Sex with Men.
AIDS Behav;
25(4): 1001-1012, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33044687
5.
Cabotegravir Is Not Associated With Weight Gain in Human Immunodeficiency Virus-uninfected Individuals in HPTN 077.
Clin Infect Dis;
70(2): 319-322, 2020 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31125395
6.
Developing and Assessing the Feasibility of a Home-based Preexposure Prophylaxis Monitoring and Support Program.
Clin Infect Dis;
68(3): 501-504, 2019 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29982304
7.
Phase 1 Pharmacokinetic Trial of 2 Intravaginal Rings Containing Different Dose Strengths of Vicriviroc (MK-4176) and MK-2048.
Clin Infect Dis;
68(7): 1129-1135, 2019 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289444
8.
Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study.
Clin Infect Dis;
68(12): 2010-2017, 2019 05 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-30239620
9.
Addressing Gaps in HIV Preexposure Prophylaxis Care to Reduce Racial Disparities in HIV Incidence in the United States.
Am J Epidemiol;
188(4): 743-752, 2019 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30312365
10.
High Interest in Doxycycline for Sexually Transmitted Infection Postexposure Prophylaxis in a Multicity Survey of Men Who Have Sex With Men Using a Social Networking Application.
Sex Transm Dis;
46(4): e32-e34, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30870327
11.
Comparison of Measures of Adherence to Human Immunodeficiency Virus Preexposure Prophylaxis Among Adolescent and Young Men Who Have Sex With Men in the United States.
Clin Infect Dis;
66(2): 213-219, 2018 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29020194
12.
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
PLoS Med;
15(11): e1002690, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30408115
13.
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy.
Antimicrob Agents Chemother;
62(1)2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038282
14.
New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact?
JAMA;
330(8): 699-701, 2023 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606684
15.
Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study.
Clin Infect Dis;
65(5): 712-718, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28505240
16.
MTN-017: A Rectal Phase 2 Extended Safety and Acceptability Study of Tenofovir Reduced-Glycerin 1% Gel.
Clin Infect Dis;
64(5): 614-620, 2017 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27986684
17.
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
PLoS Med;
14(11): e1002417, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29112956
18.
Awareness and Willingness to Use Pre-exposure Prophylaxis (PrEP) Among Men Who Have Sex with Men and Transgender Women in Brazil.
AIDS Behav;
21(5): 1278-1287, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-27531461
19.
Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.
Clin Infect Dis;
62(9): 1172-7, 2016 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26797207
20.
Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.
Curr HIV/AIDS Rep;
13(2): 116-24, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26898645